Earnings

Lowe’s cuts full-year sales forecast, as spending on do-it-yourself projects weakens

In this article

A Lowe’s Home Improvement Warehouse worker collects carts in a parking lot on August 17, 2022 in Houston, Texas. 
Brandon Bell | Getty Images News | Getty Images

Lowe’s cut its full-year outlook Tuesday, as lumber prices fell and do-it-yourself customers bought fewer discretionary items.

It lowered its forecast even as it beat Wall Street’s revenue and earnings expectations for the fiscal first quarter.

The home improvement retailer said it now expects total sales for the full year to range between $87 billion and $89 billion, lower than the $88 billion to $90 billion it had previously forecast. It said it expects same-store sales to decline by 2% to 4% this fiscal year, below the flat to down 2% that it had said before.

Shares dipped in premarket trading.

Here’s what the home improvement retailer reported for the three-month period ended May 5 compared with what Wall Street was expecting, based on a survey of analysts by Refinitiv:

  • Earnings per share: $3.67 adjusted vs. $3.44 expected
  • Revenue: $22.35 billion vs. $21.6 billion expected

Lowe’s net income for the three-month period was $2.26 billion, or $3.77 per share, compared with $2.33 billion, or $3.51 per share, a year earlier.

Net sales fell to $22.35 billion from $23.66 billion in the year-ago period, but exceeded Wall Street’s expectations.

Shares of Lowe’s closed Monday at $203.15, bringing the company’s market value to $121.15 billion. Its shares are up nearly 2% so far this year, trailing the S&P 500’s gains of 9%.

This is breaking news. Please check back for updates.

Products You May Like

Articles You May Like

IRS aims to more than double its audit rate for wealthiest taxpayers in strategic plan update
It’s been a great run for Wall Street, but Main Street is feeling left out
‘Trader justice’: Ex-SocGen trader fired for risky bets claims he was made a ‘scapegoat’
FTC challenges ‘junk’ patents held by 10 drugmakers, including for Novo Nordisk’s Ozempic
Bitcoin sinks to $57,000 to start May as investors brace for Fed rate decision

Leave a Reply

Your email address will not be published. Required fields are marked *